Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease
…, S Gräber, E Kuder-Buletta, C LaFougere, C Laske… - Nature medicine, 2019 - nature.com
Neurofilament light chain (NfL) is a promising fluid biomarker of disease progression for
various cerebral proteopathies. Here we leverage the unique characteristics of the Dominantly …
various cerebral proteopathies. Here we leverage the unique characteristics of the Dominantly …
White matter hyperintensities are a core feature of Alzheimer's disease: evidence from the dominantly inherited Alzheimer network
Objective White matter hyperintensities (WMHs) are areas of increased signal on T2‐weighted
magnetic resonance imaging (MRI) scans that most commonly reflect small vessel …
magnetic resonance imaging (MRI) scans that most commonly reflect small vessel …
Innovative diagnostic tools for early detection of Alzheimer's disease
… Author links open overlay panel Christoph Laske a b , Hamid R. Sohrabi c d , Shaun M. Frost
e f , Karmele López-de-Ipiña g , Peter Garrard h , Massimo Buscema i j , Justin Dauwels k , …
e f , Karmele López-de-Ipiña g , Peter Garrard h , Massimo Buscema i j , Justin Dauwels k , …
BDNF serum and CSF concentrations in Alzheimer's disease, normal pressure hydrocephalus and healthy controls
C Laske, E Stransky, T Leyhe, GW Eschweiler… - Journal of psychiatric …, 2007 - Elsevier
Alzheimer’s disease (AD) and normal pressure hydrocephalus (NPH) are common forms of
dementia in the elderly. Recent findings have suggested an involvement of brain-derived …
dementia in the elderly. Recent findings have suggested an involvement of brain-derived …
Safety and efficacy of semorinemab in individuals with prodromal to mild Alzheimer disease: a randomized clinical trial
…, T Grimmer, ME Kottke-Arbeiter, C Laske… - JAMA …, 2022 - jamanetwork.com
Importance Neurofibrillary tangles composed of aggregated tau protein are one of the
neuropathological hallmarks of Alzheimer disease (AD) and correlate with clinical disease severity…
neuropathological hallmarks of Alzheimer disease (AD) and correlate with clinical disease severity…
[HTML][HTML] Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research
…, T Foroud, M Carrillo, N Graff-Radford, C Laske… - Alzheimer's & …, 2015 - Elsevier
The lack of readily available biomarkers is a significant hindrance toward progressing to
effective therapeutic and preventative strategies for Alzheimer's disease (AD). Blood-based …
effective therapeutic and preventative strategies for Alzheimer's disease (AD). Blood-based …
Antidepressant effects of augmentative transcranial magnetic stimulation: randomised multicentre trial
…, B Haya, T Kammer, B Langguth, C Laske… - The British Journal of …, 2007 - cambridge.org
BackgroundRepetitive transcranial magnetic stimulation (rTMS) has been proposed as a new
treatment option for depression. Previous studies were performed with low sample sizes in …
treatment option for depression. Previous studies were performed with low sample sizes in …
Exercise-induced normalization of decreased BDNF serum concentration in elderly women with remitted major depression
C Laske, S Banschbach, E Stransky… - International Journal …, 2010 - academic.oup.com
Major depression (MD) has been associated with decreased brain-derived neurotrophic
factor (BDNF) serum levels, while antidepressant drugs were found to increase these …
factor (BDNF) serum levels, while antidepressant drugs were found to increase these …
Higher BDNF serum levels predict slower cognitive decline in Alzheimer's disease patients
C Laske, K Stellos, N Hoffmann… - International Journal …, 2011 - academic.oup.com
The neurotrophin brain-derived neurotrophic factor (BDNF) plays a critical role in neuronal
survival, synaptic plasticity, and memory. Several recent studies have demonstrated altered …
survival, synaptic plasticity, and memory. Several recent studies have demonstrated altered …
[HTML][HTML] 24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trial
Background Nutrition is an important modifiable risk factor in Alzheimer's disease. Previous
trials of the multinutrient Fortasyn Connect showed benefits in mild Alzheimer's disease …
trials of the multinutrient Fortasyn Connect showed benefits in mild Alzheimer's disease …